HighTower Advisors LLC Sells 15,738 Shares of Zimmer Biomet Holdings, Inc. $ZBH

HighTower Advisors LLC reduced its stake in Zimmer Biomet Holdings, Inc. by 31.0% in the third quarter, selling 15,738 shares but still retaining 34,958 shares valued at approximately $3.44 million. Zimmer Biomet recently exceeded quarterly earnings and revenue estimates, provided a positive FY2026 EPS guidance, and announced a quarterly dividend of $0.24. The company maintains a “Hold” consensus rating from analysts with an average price target of $106.20, and institutional investors hold a significant 88.89% of its stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin